Collectively, our results show that β-elemene inhibits NSCLC cell growth via ERK1/2- and AMPKα-mediated inhibition of transcription factor Sp1, followed by reduction in DNMT1 protein expression. The gene discussed is MAPK3; the disease is non-small cell lung carcinoma.